Mitochondrial DNA and disease

Annals of Medicine

Volumn 29, Issue 3, 1997, Pages 235-246

  Suomalainen, Anu ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Encephalopathy; Mitochondrial disease; mtDNA mutations; Myopathy; Respiratory chain

Indexed keywords

MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; CARDIOMYOPATHY; CELL ENERGY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRAOCULAR MUSCLE; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HEARING IMPAIRMENT; HUMAN; INHERITANCE; MYOPATHY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030879372     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999341     Document Type: Review

References (119)

1. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
2. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 1980; 77: 6715-9.
3. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992; 61: 1175-212.
4. Nass MMK, Nass S. Intramitochondrial fibers with DNA characteristics. J Cell Biol 1963; 19: 593-629.
5. Holt IJ, Herding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
6. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-30.
7. Holt IJ, Harding AE, Cooper JM, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989; 26: 699-708.
8. Moraes CT, DiMauro S, Zevianl M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
9. Brockington M, Alsanjari N, Sweeney MG, Morgan-Hughes JA, Scaravilli F, Harding AE. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: a molecular genetic and pathological study. J Neurol Sci 1995; 131: 78-87.
10. Rötig A, Colonna M, Bonnefont JP, et al. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1989; i: 902-3.
11. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Mol Genet 1993; 2: 1619-24.
12. Poulton J, Morten KJ, Weber K, Brown GK, Bindoff L. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome? Hum Mol Genet 1994; 3: 947-51.
13. 8344Lys point mutation in myoclonus epilepsy and ragged-red-fiber disease. Eur J Hum Genet 1993; 1: 88-95.
14. (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992; 51: 1201-12.
15. 3243Leu point mutation of mitochondrial DNA in MELAS patients and its effects on mitochondrial transcription. Hum Mol Genet 1993; 2: 525-34.
16. Leu(UUR)A→G (3243) mutation. A clinical and genetic study. Brain 1995; 118: 721-34.
17. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993; 4: 289-94.
18. Reid FM, Vernham GA, Jacobs HT. Complete mtDNA sequence of a patient in a maternal pedigree with sensorineural deafness. Hum Mol Genet 1994; 3: 1435-6.
19. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
20. Leu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990; 173: 816-22.
21. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993; 2: 2081-7.
22. Goto Y-i, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991; 1097: 238-40.
23. Leu(UUR)gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochem Biophys Res Commun 1994; 202: 1624-30.
24. Manfredi G, Schon EA, Moraes CT, et al. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord 1995; 5: 391-8.
25. Lys mutation. Cell 1990; 61: 931-7.
26. Lys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992; 51: 1213-7.
27. Lys gene. Eur J Hum Genet 1993; 1: 80-7.
28. Ser(UCN)gene. Hum Mol Genet 1995; 4: 1421-7.
29. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial . DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
30. de Vries DD, van Engelen BGM, Gabreëls FJM, Ruitenbeek W, van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993; 34: 410-2.
31. De Meirleir L, Seneca S, Lissens W, Schoentjes E, Desprechins B. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995; 13: 242-6.
32. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995; 38: 468-72.
33. Ser(UCN) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 1995; 214: 86-93.
34. Cys gene associated with mitochondrial encephalopathy. Hum Mutat 1996; 7: 158-63.
35. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE. A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological and molecular genetic study. Ann Neurol 1995; 37: 400-3.
36. Thr gene associated with a mitochondrial encephalomyopathy. Biochem Biophys Res Commun 1996; 225: 180-5.
37. Leu(UUR) gene an etiologic hot spot? J Clin Invest 1993; 92: 2906-15.
38. Leu(UUR) gene. Neurology 1995; 45: 286-92.
39. Hanna MG, Nelson I, Sweeney MG, et al. Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different pnenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet 1995; 56: 1026-33.
40. Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet 1995; 56: 1017-25.
41. Tanaka M, Ino H, Ohno K, et al. Mitochondrial mtDNA mutation in fatal infantile cardiomyopathy. Lancet 1990; 336: 1452.
42. Santorelli FM, Mak S-C, Vàzquez-Acevedo M, et al. A novel mitochondrial DNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995; 216: 835-40.
43. Leu(UUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994; 3: 37-43.
44. Glycine gene. Am J Hum Genet 1994; 55: 437-46.
45. Ile mutation in fatal cardiomyopathy. Biochem Biophys Res Commun 1992; 186: 47-53.
46. Lys gene (G8363A). Am J Hum Genet 1996; 58: 933-9.
47. Casali C, Santorelli FM, D'Amati G, Bernucci P, DeBiase L, DiMauro S. A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995; 213: 588-93.
48. Leu(UUR). Lancet 1991; 338: 143-7.
49. Leu(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 1992; 31: 672-5.
50. Bindoff LA, Howell N, Poulton J, et al. Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 1993; 268: 19559-64.
51. Moraes CT, Ciacci F, Bonilla E, Ionasescu V, Schon EA, DiMauro S. A mitochondrial tRNA anticodon swap associated with a muscle disease. Nat Genet 1993; 4: 284-8.
52. (UUR) gene. Q J Med 1993; 86: 709-13
53. thr mutation in fatal infantile respiratory enzyme deficiency. Biochem Biophys Res Commun 1991; 176: 1112-5.
54. Lauber J, Marsac C, Kadenbach B, Seibel P. Mutations in mitochondrial tRNA genes: a frequent cause of neuromuscular diseases. Nucleic Acids Res 1991; 19: 1393-7.
55. Asn gene. Biochem Biophys Res Commun 1994; 204: 482-9.
56. Ile gene is associated with progressive external ophthalmoplegia. Biochem Biophys Res Commun 1996; 220: 623-7.
57. Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991; 49: 939-50.
58. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus M-L. A new mtDNA mutation associated with Leber hereditary optic neuropathy. Am J Hum Genet 1991; 48: 1147-53.
59. Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992; 187: 1551-7.
60. Lamminen T, Majander A, Juvonen V, et al. A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1995; 56: 1238-40.
61. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenese subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994; 91: 6206-10.
62. de Vries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996; 58: 703-11.
63. Leu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroplastic anaemia. Br J Haematol 1996; 93: 845-55.
64. Silvestri G, Ciafaloni E, Santorelli FM, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ('MERRF mutation'). Neurology 1993; 43: 1200-6.
65. (8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1993; 52: 551-6.
66. Lys gene: two genotypes produce similar phenotypes. Mol Cell Biol 1995; 15: 2872-81.
67. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry and molecular genetics. Ann Neurol 1992; 31: 391-8.
68. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
69. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.
70. Reardon W, Ross RJM, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992; 340: 1376-9.
71. Leu(UUR) gene point mutation. Muscle Nerve 1995; Suppl 3: S124-30.
72. Lys mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992; 51: 1187-200.
73. Lys and premature translation termination. Nat Genet 1995; 10: 47-55.
74. Clayton DA. Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol 1991; 7: 453-78.
75. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 1992; 89: 4221-5.
76. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992; 50: 852-8.
77. Tatuch Y, Pagon RA, Vlcek B, Roberts R, Korson M, Robinson BH. The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families. Eur J Hum Genet 1994; 2: 35-43.
78. Mäkelä-Bengs P, Suomalainen A, Majander A, et al. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr Res 1995; 37: 634-9.
79. Nikoskelainen EK, Marttila RJ, Huoponen K, et al. Leber's 'plus': neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995; 59: 160-4.
80. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Herding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-37.
81. Bu X, Rotter JI. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci USA 1991; 88: 8198-202.
82. Chalmers RM, Davis MB, Sweeney MG, Wood NW, Harding AE. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet 1996; 59: 103-8.
83. Harding AE, Riordan-Eva P, Govan GG. Mitochondrial DNA diseases: genotype and phenotype in Leber's hereditary optic neuropathy. Muscle Nerve 1995; Suppl 3: S82-4.
84. Mackey DA, Oostra R-J, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996; 59: 481-5.
85. Grivell LA. Nucleo-mitochondrial interactions in mitochondrial gene expression. Crit Rev Biochem Mol Biol 1995; 30: 121-64.
86. Moraes CT, Shanske S, Tritschler H-J, et al. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991; 48: 492-501.
87. Tritschler H-J, Andreetta F, Moraes CT, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992; 42: 209-17.
88. Larsson N-G, Oldfors A, Holme E, Clayton DA. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun 1994; 200: 1374-81.
89. Poulton J, Morten K, Freeman-Emmerson C, et al. Deficiency of the human mitochondrial transcription factor h-mtTFA in infantile mitochondrial myopathy is associated with mtDNA depletion. Hum Mol Genet 1994; 3: 1763-9.
90. Davis AF, Ropp PA, Clayton DA, Copeland W. Mitochondrial DNA polymerase γ is expressed and translated in the absence of mitochondrial DNA maintenance and replication. Nucleic Acids Res 1996; 24: 2753-9.
91. Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-11.
92. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992; 90: 61-6.
93. Servidei S, Zeviani M, Manfredi G, et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology 1991; 41: 1053-9.
94. Melberg A, Lundberg PO, Henriksson KG, Olsson Y, Stålberg E. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve 1996; 19: 751-7.
95. Suomalainen A, Majander A, Wallin M, et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical and molecular genetic features of the 10q-linked disease. Neurology (in press).
96. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995; 9: 146-51.
97. Kaukonen JA, Amati P, Suomalainen A, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996; 58: 763-9.
98. Tiranti V, Rossi E, Ruiz-Carrillo AR, et al. Chromosomal localization of mtTF1, mtSSB and endoG, three human housekeeping genes involved in mitochondrial biogenesis. Genomics 199; 25: 559-64.
99. Ohno K, Tanaka M, Sahashi K, et al. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 1991; 29: 364-9.
100. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.
101. Suomalainen A, Paetau A, Leinenen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992; 340: 1319-20.
102. Bohlega S, Tanji K, Santorelli FM, Hirano M, Aljishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996; 46: 1329-34.
103. Oldfors A, Larsson N-G, Lindberg C, Holme E. Mitochondrial DNA deletions in inclusion body myositis. Brain 1993; 116: 325-36.
104. Singer TP, Ramsey RR. Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett 1990; 274: 1 -8.
105. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989; i: 1269.
106. Blass JP, Baker AC, Ko L, Black RS. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch Neurol 1990; 47: 864-9.
107. Parker WD, Filley CM, Parks JK. Cytochrome c oxidase deficiency in Alzheimer's disease. Neurology 1990; 40: 1302-3.
108. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17: 171-84.
109. Hutchin T, Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer's disease. Proc Natl Acad Sci USA 1995; 92: 6892-5.
110. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337: 508-10.
111. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990; 18: 6927-33.
112. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992; 2: 324-39.
113. Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 1992; 2: 318-23.
114. Harman D. The aging process. Proc Natl Acad Sci USA 1981; 78: 7124-8.
115. leu(UUR) mutation and successful therapy with coenzyme Q10. Endocr J 1995; 42: 141-5.
116. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/ chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci USA 1989; 86: 7952-6.
117. Bakker HD, Scholte HR, Jenesons JA, Busch HF, Abeling NG, van Gennip AH. Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis. J Inher Metab Dis 1994; 17: 196-204.
118. + and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome. Life Sci 1996; 58: 691-9.
119. Seibel P, Trappe J, Villani G, Klopstock T, Papa S, Reichmann H. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res 1995; 23: 10-7.